Treatment withdrawal is feasible in ra remission

Access through your institution Buy or subscribe Many patients with rheumatoid arthritis (RA) can remain in remission after tapering or withdrawal of DMARD therapy, according to findings

from the phase III RETRO trial. Among 282 patients with sustained (≥12 months) remission, 43.3% of those who then discontinued DMARDs at 6 months maintained relapse-free remission at 12

months, compared with 58.6% of those whose dose of DMARDs was halved and 81.2% who continued to receive a full dose. Most patients whose disease relapsed regained remission after restarting

treatment. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get

Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only

$17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout

ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES ORIGINAL ARTICLE * Tascilar, K. et al. Treatment tapering

and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial. _Lancet Rheumatol._

https://doi.org/10.1016/S2665-9913(21)00220-4 (2021) Article  PubMed  PubMed Central  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews

Rheumatology http://www.nature.com/nrrheum/ Sarah Onuora Authors * Sarah Onuora View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR

Correspondence to Sarah Onuora. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Onuora, S. Treatment withdrawal is feasible in RA remission. _Nat Rev

Rheumatol_ 17, 707 (2021). https://doi.org/10.1038/s41584-021-00717-9 Download citation * Published: 27 October 2021 * Issue Date: December 2021 * DOI:

https://doi.org/10.1038/s41584-021-00717-9 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative